PatternsRadar
Sign in

SYMBIOTECSYMBIOTEC

NSEASM Stage I
Full chart
1,611.30INR-31.10 (-1.89%)Close · 13 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹10,354 CrMarket cap
—P/E (TTM)
27.5%Delivery

Filings & corporate actions

2 results filed
CSV
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone+19.0%NSE
  • 15 OctshareholdingShareholding · 30 Sept 2026+0.1%NSE
  • 21 SeptresultsResults · Q1 FY27 · consolidated and standalone-3.0%NSE
  • 1 SeptshareholdingShareholding · 31 Aug 2026NSE

Reaction to results · all yearsrose on day 0 in 1 of 2 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026+19.0%+26.7%—11.0×
Q1 FY2721 Sept 2026-3.0%-1.0%+3.6%—
Average+8.0%+12.8%+3.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

CSV
Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ+28.3%
Profit QoQ+268.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open1,635.00
Day range1,586.60 – 1,635.00
52-week range—
From 52w high—
RSI (14)71.7
ATR (14)79.01
Volume2.72L
Avg volume (20D)9.51L
Rel volume0.29×
Volatility (1Y)65.6%
Turnover₹43.8Cr
Traded value (NSE)₹43.8Cr
VWAP1,612.32
SMA 50 / 2001,205.76 / —
Price band20%

Delivery percentage

Latest · 13 Nov 202627.5%
20-day avg33.6%
1-year avg31.9%
Percentile (own history)27th
Range10.7–49.9%
Sessions51

Over the last 20 sessions SYMBIOTEC settled 33.6% of its traded quantity, which is ordinary for an NSE equity.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders81.7K · -80.9% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy72 days ago
IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAACUTAASSAILIFEDRREDDY

Performance returns

CSV
1D1W1M3M6M1Y
Price-1.89%+6.45%+28.57%———

Valuation

CSV
Market cap₹10,354 Cr
Market cap (NSE)₹10,354 Cr
Free-float cap₹6,908 Cr
P/E (TTM)—
EPS (TTM)—
P/B7.6
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity0.24
Shares outstanding6.43Cr
Listed1 Sept 2026

Ownership

CSV
Promoter33.28%
Promoter Δ QoQ0.00 pp
Public66.72%
FII3.79%
DII33.17%
Pledged38.54%

Quarterly results · consolidated

CSV
Q1 FY27Q2 FY27
Revenue (₹ Cr)218.2279.9
YoY chg——
Net profit (₹ Cr)14.151.7
YoY chg——
Net margin6.4%18.5%
EPS2.248.20

Shareholding over time

CSV

By quarter

30 Sept 2026 · promoter 33.28% · public 66.72%
31 Aug 2026: promoter 33.28%30 Sept 2026: promoter 33.28%
2026-082026-09
  • Promoter
  • Public and others
Promoter
33.28%
Public
66.72%
Promoter change
0.00 pp
Filed
15 Oct 2026
FII
3.79%
DII
33.17%
Promoter pledged
38.54%

Who the public is

Mutual funds
12.18%

+6.64 pp QoQ

Insurance
1.07%

0.00 pp QoQ

FPI
3.79%

+1.11 pp QoQ

Retail ≤ ₹2L
6.70%

-8.95 pp QoQ

HNI > ₹2L
1.11%

+0.16 pp QoQ

NRI
0.98%

+0.07 pp QoQ

Bodies corporate
1.91%

+1.81 pp QoQ

Shareholders
81,747

-80.9% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Satwani Holdings LLPPromoter · Corporate15.28%
Rosewood InvestmentsCorporate14.07%
Business Excellence Trust Iii - India Business Excellence Fund IiiAIF10.24%
Mirae Asset Aggressive Hybrid FundMutual fund6.00%
Anil SatwaniPromoter · Individual4.37%
Kashish SatwaniPromoter · Individual4.28%
Anil SatwaniPromoter · Individual3.42%
Anil SatwaniPromoter · Individual3.42%
Valuequest Founders Conviction LvfAIF2.92%
Think India Opportunities Master Fund LpCorporate2.76%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

CSV
Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

CSV
Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

CSV
Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
16
16 open-market of the newest 16
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
5 Oct 2026NISHIKANT Digambar GHADGEEmployeeSell1.0K₹11.8L1,180.0019.8K → 18.8K0.03%-0.00 pp7(2)told 1 Oct 2026
5 Oct 2026MITESH PATELEmployeeSell11.5K₹1.3Cr1,168.6538.6K → 27.1K0.04%-0.02 pp7(2)told 5 Oct 2026
5 Oct 2026JITENDRA SHARMAEmployeeSell9.2K₹1.1Cr1,164.6524.3K → 15.1K0.02%-0.01 pp7(2)told 5 Oct 2026
5 Oct 2026DR.PRATIMA KHATRIEmployeeSell5.5K₹64.6L1,175.2220.6K → 15.1K0.02%-0.01 pp7(2)told 5 Oct 2026
5 Oct 2026DHARM SHANKER PANDEYEmployeeSell12.5K₹1.5Cr1,173.6425.5K → 13.0K0.02%-0.02 pp7(2)told 5 Oct 2026
5 Oct 2026DEVENDRA SINGH KUSHWAHEmployeeSell1.0K₹11.7L1,174.4717.1K → 16.1K0.03%-0.00 pp7(2)told 1 Oct 2026
5 Oct 2026DEEPAK PATELEmployeeSell2.0K₹23.7L1,184.9929.0K → 27.0K0.04%-0.00 pp7(2)told 5 Oct 2026
5 Oct 2026VIVEK ASTHANAEmployeeSell1.0K₹10.9L1,093.7414.5K → 13.5K0.02%-0.00 pp7(2)told 30 Sept 2026
5 Oct 2026VIJAY SHARMAEmployeeSell2.0K₹23.8L1,190.009.3K → 7.3K0.01%-0.00 pp7(2)told 5 Oct 2026
5 Oct 2026VIJAY SHARMAEmployeeSell900₹9.4L1,049.8910.2K → 9.3K0.02%-0.00 pp7(2)told 30 Sept 2026
5 Oct 2026SUNIL KUMAR PANDEYEmployeeSell8.5K₹1.0Cr1,183.6313.7K → 5.2K0.01%-0.02 pp7(2)told 5 Oct 2026
5 Oct 2026SUMAN PODDEREmployeeSell15.0K₹1.8Cr1,177.3845.3K → 30.3K0.05%-0.02 pp7(2)told 5 Oct 2026
5 Oct 2026SACHIN MADHUKAR CHAUDHARIEmployeeSell2.5K₹29.3L1,172.6414.2K → 11.7K0.02%-0.00 pp7(2)told 5 Oct 2026
5 Oct 2026RAMAN PRASAD VERMAEmployeeSell17.0K₹2.0Cr1,168.6557.9K → 40.9K0.06%-0.02 pp7(2)told 5 Oct 2026
5 Oct 2026RAJESH BHIMRAO MESHRAMEmployeeSell7.0K₹80.8L1,153.9612.4K → 5.4K0.01%-0.01 pp7(2)told 5 Oct 2026
5 Oct 2026VIVEK ASTHANAEmployeeSell5.5K₹58.0L1,054.7820.0K → 14.5K0.02%-0.01 pp7(2)told 30 Sept 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 2 Sept 2026

CSV
12 of 21 deals
By year
DateDealClientQuantityPriceValue
2 Sept 2026Sell · bulkJUNOMONETA FINSOL PRIVATE LIMITED3.58L1,123.68₹40.2Cr
2 Sept 2026Buy · bulkJUNOMONETA FINSOL PRIVATE LIMITED3.58L1,123.40₹40.2Cr
1 Sept 2026Buy · bulkJUNOMONETA FINSOL PRIVATE LIMITED18.76L1,068.22₹200.4Cr
1 Sept 2026Sell · bulkJUNOMONETA FINSOL PRIVATE LIMITED18.47L1,066.89₹197.1Cr
1 Sept 2026Sell · bulkIRAGE BROKING SERVICES LLP9.29L1,057.96₹98.3Cr
1 Sept 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED8.42L1,063.88₹89.6Cr
1 Sept 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED8.42L1,063.42₹89.6Cr
1 Sept 2026Buy · bulkIRAGE BROKING SERVICES LLP7.52L1,079.32₹81.2Cr
1 Sept 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED6.68L1,105.17₹73.8Cr
1 Sept 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED6.68L1,104.29₹73.8Cr
1 Sept 2026Buy · bulkPURE BROKING PRIVATE LIMITED6.28L1,049.01₹65.9Cr
1 Sept 2026Sell · bulkPURE BROKING PRIVATE LIMITED6.27L1,049.44₹65.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

CSV
Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

CSV
Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

13 Nov 2026
  • Short-term ASM · Stage I · since 9 Nov 2026 — Short-term Additional Surveillance Measure: a sharp move over a few days; a higher margin applies while it lasts.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

CSV
₹ crore, as filed
 Q1 FY27Q2 FY27
Revenue from operations218.2279.9
Other income0.30.1
Total income218.5280.0
Total expenses201.0216.0
└ Finance costs6.25.7
└ Depreciation21.821.9
Profit before tax17.564.0
Tax expense3.512.3
Net profit14.151.7
EPS2.248.20
Net margin6.45%18.48%
PBT margin8.04%22.88%
Tax rate19.80%19.25%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

2 quarters on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

CSV
₹ crore, as filed

Balance sheet

 H1 FY27
Total assets2,043.9
Current assets652.2
└ Cash & equivalents21.7
└ Other bank balances0.1
└ Current investments0.0
└ Trade receivables268.3
└ Inventories303.4
Total equity1,360.8
└ Attributable to owners1,360.9
└ Non-controlling interest(0.1)
└ Share capital12.9
Borrowings333.1
└ Current170.9
└ Non-current162.2
Trade payables172.7
Current liabilities479.8
Total liabilities683.1
Net debt311.4
Debt / equity0.24
Current ratio1.36

Cash flow, year to date

 H1 FY27
Operating cash flow45.9
└ Capex(113.5)
Free cash flow(67.6)
Investing cash flow(112.2)
Financing cash flow133.7
└ Dividends paid0.0
└ Buybacks0.0
Net change in cash67.5

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

CSV
Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SYMBIOTEC at a glance

  • SYMBIOTEC closed at ₹1,611.3 on 13 Nov 2026, -1.89% on the day.
  • Delivery was 27.5% of traded quantity on 13 Nov 2026, the 27th percentile of its own 51 sessions with a reading (20-session average 33.6%, 1-year average 31.9%).
  • Market capitalisation is ₹10,354 crore, with no positive trailing earnings for a P/E.
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹280 crore, net profit ₹52 crore; the price moved +19.0% on the first session after.
  • Promoters held 33.28% at 30 Sept 2026, unchanged on the previous filing, with 38.54% of promoter shares pledged.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE899I01028
SeriesEQ
Listed1 Sept 2026
IPO price988.00 · band Rs.938 to Rs.988
IPO listing1 Sept 2026
NSE market cap · 10 Nov 2026₹9,990 Cr
Free-float market cap (NSE)₹3,111 Cr
Shares outstanding (NSE)6.43Cr
History from1 Sept 2026
Sessions51
Turnover rank#221

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 13 Nov 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE